Back

Potassium and aldosterone as determinants of new-onset atrial fibrillation

European Heart Journal

13 February 2026
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CARDIOVASCULAR PHARMACOLOGY Arrhythmias, General Atrial Fibrillation (AF) HYPERTENSION BASIC SCIENCE

Contributors

Federico Bernardo Rossi
Federico Bernardo Rossi

Author

Ambra Sammarco
Ambra Sammarco

Author

Padova University Hospital Padua , Italy

Teresa Maria Seccia
Teresa Maria Seccia

Author

Arterial Hypertension Unit Padua , Italy

You may be interested in
thumbnail
Congress Presentation
The effects of alterations of plasma electrolytes on post-repolarisation refractoriness
14 April 2026
thumbnail
Congress Session
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
19 May 2025
thumbnail
Congress Presentation
New-onset atrial fibrillation in the ICU: a temporary disturbance or a lasting burden?
21 March 2026
thumbnail
Webinar
Arrhythmias and metabolic pathways: new mechanisms, new opportunities
2 June 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources